Business
Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The rising global incidence of breast cancer, driven by lifestyle changes and an aging population, is a key market driver. Technological advancements in diagnostics and treatment, such as molecular imaging, targeted therapies, and precision medicine,
By: globenewswire_fr
- Oct 02 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS